Polypharmacology

lt;b> Zhiguo Wang PhD received his PhD in cardiovascular pharmacology from McGill University, Canada. He is presently the Director of the Division of Drug Discovery, Meditech Institute of Research and Advance (USA) and a Distinguished Professor in the Department of Pharmacology, Harbin Medical University. He is an author of over 150 research articles in prestigious scientific journals and of 6 monographs and 15 book chapters with renowned scientific publishers. His research interests cover cardiovascular disease and pharmacology, molecular pharmacology, epigenetic polypharmacology. His research group is one of the earliest investigators who proposed "one drug, multiple targets" polypharmacology concept and provided the experimental evidence in support of the epigenetic polypharmacology.

PART I. Polypharmacology as a New Branch of Pharmacology: Concept and Principles.- Basics of Polypharmacology.- Polypharmacology in Clinical Applications: Multitarget Multidrug-combination (MTMD-C).-  Polypharmacology in Clinical Applications: Multitarget Multidrug-single-formulation (MTMD-SF).- Polypharmacology in Clinical Applications: Multitarget Single-drug (MTSD).- Polypharmacology in Drug Discovery: Designed Epigenetic MTSD and Small-molecule MTSD.- Anti-cancer Polypharmacology.-  Cardiovascular Polypharmacology.-  Neuronal Polypharmacology.- Pulmonary Polypharmacology.- Polypharmacology of Metabolic Disease.- Polypharmacology of Infectious Disease.- Polypharmacology of Inflammation.- Anti-psychotics Polypharmacology.-  Anti-aging Polypharmacology.- Polypharmacology in Drug Repurposing.- Polypharmacology and Unintended Drug Promiscuity.- Polypharmacology Pharmacokinetics.- The Future of Polypharmacology.- PART II. Polypharmacology in New Drug Development: Strategies and Protocols.- Designed MTSD Discovery Process.- Designed MTSD Discovery Strategies.- Designed MTSD Discovery Technologies.-  Designed MTSD Discovery Databases.-  Designed MTSD Target Deconvolution.-Designed MTSD Target Validation.- Designed MTSD Lead Identification and Optimization.-  Designed MTSD Discovery Protocols.-  Natural Products in MTSD Discovery.- Polypharmacology Procedures for Drug Repurposing.- Polypharmacology Procedures for Drug Promiscuity Discovery.